Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2017 Feb;31(2):342.
doi: 10.1038/eye.2016.238. Epub 2016 Nov 4.

Aflibercept in diabetic macular edema: evaluating efficacy as a primary and secondary therapeutic option

D Călugăru  1 , M Călugăru  2
Affiliations
Comment

Aflibercept in diabetic macular edema: evaluating efficacy as a primary and secondary therapeutic option

D Călugăru et al. Eye (Lond). 2017 Feb.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Comment on

References

    1. Ashraf M, Souka A, Adelman R, Forster SH. Aflibercept in diabetic macular edema: evaluating efficacy as a primary and secondary therapeutic option. Eye; e-pub ahead of print 26 August 2016; doi:10.1038/eye.2016.174. - PMC - PubMed
    1. Wood EH, Karth PA, Moshfeghi DM, Leng T. Short-term outcomes of aflibercept for diabetic macular edema in patients with incomplete response to ranibizumab and/or bevacizumab. Ophthalmic Surg Lasers Imaging Retina 2015; 46(9): 950–954. - PubMed
    1. Rahimy E, Shahlace A, Ali Khan M, Ying GS, Maguire JI, Ho AC et al. Conversion to aflibercept after prior anti-VEGF therapy for persistent diabetic macular edema. Am J Ophthalmol 2016; 164(4): 118–127. - PubMed
    1. Grover S, Murthy RK, Brar VS, Chalam KV. Normative data for macular thickness by high-definition spectral-domain optical coherence tomography (spectralis). Am J Ophthalmol 2009; 148(2): 266–271. - PubMed
    1. Călugăru D, Călugăru M. Conversion to aflibercept after prior anti-VEGF therapy for persistent diabetic macular edema. Am J Ophthalmol 2016; 168(8): 290–291. - PubMed

Substances

LinkOut - more resources